Dec. 11, 2015 6:30 pm

The Plaza | New York, NY


Heart disease is the number one cause of death globally and affects millions around the world. The Cardiovascular Research Foundation (CRF) is dedicated to improving the survival and quality of life for people suffering from heart disease through research and education. This year’s gala celebrates the breakthrough treatments and transformative technologies that save lives and drastically improve patient outcomes.

Proceeds from the evening will benefit CRF’s medical research and educational programs.


One of the world’s most accomplished and respected public servants, Dr. Henry Kissinger has affected much of the history of the last half century through his work as a renowned scholar, foreign policy advisor, and prolific author. As former US Secretary of State and National Security Advisor, Dr. Kissinger pioneered the policy of détente with the Soviet Union, orchestrated the opening of relations with the People's Republic of China, and brokered a peace treaty between Egypt and Israel after the Yom Kippur War. In addition, he negotiated the Paris Peace Accords, ending American involvement in the Vietnam War, for which he was awarded the Nobel Peace Prize in 1973. Dr. Kissinger is the founder and chairman of Kissinger Associates, an international consulting firm, and has authored nearly 20 books in politics and international relations.

Special Guest
Roman W. DeSanctis, MD


Since its inception in 1991, the Cardiovascular Research Foundation (CRF) has played a major role in realizing dramatic improvements in treating heart disease by establishing the safe use of new technologies, drugs, and therapies in interventional cardiovascular medicine. Guided by visionary physicians who are passionate about advancing the field, CRF’s mission is to improve the survival and quality of life for those suffering from heart disease around the world.

CRF’s role in interventional cardiovascular medicine is unique. By providing research, evaluation, and education under one roof, CRF has the ability to generate important research questions, test and refine groundbreaking new therapies, and ensure that these treatments are available to patients at the earliest opportunity.

For more information, please visit

Martin B. Leon, MD Founder and Chairman Emeritus Co-Director, M

Martin B. Leon, MD
Founder and Chairman Emeritus
Co-Director, Medical Research and
Education Division

Gregg W. Stone, MD Immediate Past Chairman Co-Director, Medical

Gregg W. Stone, MD
Immediate Past Chairman
Co-Director, Medical Research and
Education Division

Jack Lewin, MD President and Chief Executive Officer

Jack Lewin, MD
President and Chief Executive Officer

  • Alexandre Abizaid, MD, PhD
  • Andrea Abizaid, MD, PhD
  • Ali F. Aboufares, MD
  • Ziad A. Ali, MD, DPhil
  • Ori Ben-Yehuda, MD
  • Michael A. Borger, MD, PhD
  • Michael B. Collins, MD
  • Antonio Colombo, MD
  • George D. Dangas, MD, PhD
  • Philippe Généreux, MD
  • Isaac George, MD
  • Juan F. Granada, MD
  • William A. Gray, MD
  • Rebecca T. Hahn, MD
  • Allen Jeremias, MD, MSc
  • Greg L. Kaluza, MD, PhD
  • Dimitri Karmpaliotis, MD, PhD
  • Ajay J. Kirtane, MD, SM
  • Ioanna Kosmidou, MD, PhD
  • Susheel Kodali, MD
  • Akiko Maehara, MD
  • Roxana Mehran, MD
  • James K. Min, MD
  • Gary S. Mintz, MD
  • Jeffrey W. Moses, MD
  • Tamim Nazif, MD
  • Manish Parikh, MD
  • LeRoy E. Rabbani, MD
  • Robert J. Sommer, MD
  • Paul S. Teirstein, MD
  • Giora Weisz, MD
  • Mathew Williams, MD
  • Steven D. Wolff, MD, PhD
  • Geng-Hua Yi, MD
  • Eric B. Woldenberg, Esq
  • Chairman
  • Joseph G. Beck
  • Colette Y. Gardner
  • Robert L. Glenning
  • William A. Himmelsbach, MPH, FACHE
  • Karen G. Krasney, JD
  • Jack Lewin, MD
  • Frank Litvack, MD
  • Jeffrey W. Moses, MD
  • Arthur J. Pergament
  • Eric A. Rose, MD
  • Marvin L. Woodall